Name | Title | Contact Details |
---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
USAID is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Curo, we are committed to clinical excellence and integrity, insuring our patients the highest quality of care and comfort. To maintain this commitment we hire only the most experienced and capable hospice and home health care professionals. Our clinical team members are experts in pain and symptom management, and our support team members are skilled in the specific issues of emotional support, spiritual counseling, and resource referral.
L&L XRay Service is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Motility Incorporated is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.